179 related articles for article (PubMed ID: 2138085)
1. Autoantibody production against the U small nuclear ribonucleoprotein particle proteins E, F and G in patients with connective tissue diseases.
Reuter R; Rothe S; Habets W; Van Venrooij WJ; Lührmann R
Eur J Immunol; 1990 Feb; 20(2):437-40. PubMed ID: 2138085
[TBL] [Abstract][Full Text] [Related]
2. Mapping of B cell epitopes on small nuclear ribonucleoproteins that react with human autoantibodies as well as with experimentally-induced mouse monoclonal antibodies.
Habets WJ; Hoet MH; De Jong BA; Van der Kemp A; Van Venrooij WJ
J Immunol; 1989 Oct; 143(8):2560-6. PubMed ID: 2477448
[TBL] [Abstract][Full Text] [Related]
3. Anti-(U1) small nuclear RNA antibodies in anti-small nuclear ribonucleoprotein sera from patients with connective tissue diseases.
van Venrooij WJ; Hoet R; Castrop J; Hageman B; Mattaj IW; van de Putte LB
J Clin Invest; 1990 Dec; 86(6):2154-60. PubMed ID: 1701452
[TBL] [Abstract][Full Text] [Related]
4. Further characterization and subcellular localization of Sm and U1 ribonucleoprotein antigens.
Habets WJ; Berden JH; Hoch SO; Van Venrooij WJ
Eur J Immunol; 1985 Oct; 15(10):992-7. PubMed ID: 2414112
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against small nuclear ribonucleoprotein components.
van Venrooij WJ
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():78-82. PubMed ID: 2956421
[TBL] [Abstract][Full Text] [Related]
6. Detection of autoantibodies in a quantitative immunoassay using recombinant ribonucleoprotein antigens.
Habets WJ; Hoet MH; Sillekens PT; De Rooij DJ; Van de Putte LB; Van Venrooij WJ
Clin Exp Immunol; 1989 May; 76(2):172-7. PubMed ID: 2527098
[TBL] [Abstract][Full Text] [Related]
7. Human anti-nuclear ribonucleoprotein antigen autoimmune sera contain a novel subset of autoantibodies that stabilizes the molecular interaction of U1RNP-C protein with the Sm core proteins.
Satoh M; Richards HB; Hamilton KJ; Reeves WH
J Immunol; 1997 May; 158(10):5017-25. PubMed ID: 9144522
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to the Sm antigen: immunological approach to clinical aspects of systemic lupus erythematosus.
Homma M; Mimori T; Takeda Y; Akama H; Yoshida T; Ogasawara T; Akizuki M
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():188-93. PubMed ID: 2441045
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
[TBL] [Abstract][Full Text] [Related]
10. [Enzyme immunoassay for the detection of autoantibodies to nRNP and Sm: a rapid and sensitive alternative to current procedures].
Blazek M; Naser W; Bayer-Beck J; Lakomek HJ; Werle E; Fiehn W
Z Rheumatol; 1992; 51(2):87-93. PubMed ID: 1615735
[TBL] [Abstract][Full Text] [Related]
11. The U2 small nuclear ribonucleoprotein particle as an autoantigen. Analysis with sera from patients with overlap syndromes.
Craft J; Mimori T; Olsen TL; Hardin JA
J Clin Invest; 1988 Jun; 81(6):1716-24. PubMed ID: 2968364
[TBL] [Abstract][Full Text] [Related]
12. IgG subclass distribution of autoantibodies to DNA and to nuclear ribonucleoproteins in autoimmune diseases.
Zouali M; Jefferis R; Eyquem A
Immunology; 1984 Mar; 51(3):595-600. PubMed ID: 6230310
[TBL] [Abstract][Full Text] [Related]
13. Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp-lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target.
Fatenejad S; Brooks W; Schwartz A; Craft J
J Immunol; 1994 Jun; 152(11):5523-31. PubMed ID: 7514640
[TBL] [Abstract][Full Text] [Related]
14. Clinical associations with autoantibody reactivities to individual components of U1 small nuclear ribonucleoprotein.
Kaneko Y; Suwa A; Hirakata M; Ikeda Y; Kuwana M
Lupus; 2010 Mar; 19(3):307-12. PubMed ID: 20015915
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies that stabilize U1snRNP are a significant component of human autoantibodies to snRNP and delay proteolysis of sm antigens in vitro.
Satoh M; Akaogi J; Kuroda Y; Nacionales DC; Yoshida H; Yamasaki Y; Reeves WH
J Rheumatol; 2004 Dec; 31(12):2382-9. PubMed ID: 15570638
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.
Combe B; Rucheton M; Graafland H; Lussiez V; Brunel C; Sany J
Clin Exp Immunol; 1989 Jan; 75(1):18-24. PubMed ID: 2702772
[TBL] [Abstract][Full Text] [Related]
17. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
Skriner K; Sommergruber WH; Tremmel V; Fischer I; Barta A; Smolen JS; Steiner G
J Clin Invest; 1997 Jul; 100(1):127-35. PubMed ID: 9202064
[TBL] [Abstract][Full Text] [Related]
18. Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies.
Mahler M; Fritzler MJ; Blüthner M
Arthritis Res Ther; 2005; 7(1):R19-29. PubMed ID: 15642139
[TBL] [Abstract][Full Text] [Related]
19. Identification of an acidic ribosomal protein reactive with anti-Sm autoantibody.
Nojima Y; Minota S; Yamada A; Takaku F
J Immunol; 1989 Sep; 143(6):1915-20. PubMed ID: 2778317
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the protein moiety of U7 small nuclear RNP particles.
Pironcheva G; Russev G
Microbios; 1994; 77(310):41-6. PubMed ID: 7512683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
